Literature DB >> 15025752

Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon.

Loes E Visser1, Fernie J A Penning-van Beest, J H P Wilson, Arnold G Vulto, A A Harrie Kasbergen, Peter A G M De Smet, Albert Hofman, Bruno H Ch Stricker.   

Abstract

Some medical textbooks on drug interactions take note of the potential interaction between laxatives and coumarin anticoagulants, but epidemiological evidence that this interaction is of practical importance is lacking. We conducted a follow-up study in a large population-based cohort to investigate which laxatives are associated with overanticoagulation during therapy with coumarins. Of the 1124 patients in the cohort, 351 developed an International Normalized Ratio > or = 6.0. The only laxative with a moderate but significantly increased relative risk of overanticoagulation was lactulose (relative risk 3.4, 95% confidence interval 2.2, 5.3). In view of the widespread use of lactulose, especially among the elderly, awareness of this potential drug interaction is required.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15025752      PMCID: PMC1884465          DOI: 10.1046/j.1365-2125.2003.02036.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  [STUDIES ON THE MECHANISM OF ACTION OF LACTULOSE (BETA-GALACTOSIDE ACTION OF LACTULOSE (BETA-GALACTOSIDO-FRUCTOSE) IN THE INTESTINE].

Authors:  K HOFFMANN; D A MOSSEL; W KORUS; J H VAN DE KAMER
Journal:  Klin Wochenschr       Date:  1964-02-01

Review 2.  Oral anticoagulant drugs.

Authors:  J Hirsh
Journal:  N Engl J Med       Date:  1991-06-27       Impact factor: 91.245

3.  Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy.

Authors:  C S Landefeld; L Goldman
Journal:  Am J Med       Date:  1989-08       Impact factor: 4.965

4.  The effect of lactulose on the faecal flora of patients with hepatic encephalopathy.

Authors:  A Vince; R Zeegen; J E Drinkwater; F O'Grady; A M Dawson
Journal:  J Med Microbiol       Date:  1974-05       Impact factor: 2.472

Review 5.  Lactulose: a review of its therapeutic and pharmacological properties with particular reference to ammonia metabolism and its mode of action of portal systemic encephalopathy.

Authors:  G S Avery; E F Davies; R N Brogden
Journal:  Drugs       Date:  1972       Impact factor: 9.546

6.  Vitamin K2 colonic and ileal in vivo absorption: bile, fatty acids, and pH effects on transport.

Authors:  D Hollander; E Rim; P E Ruble
Journal:  Am J Physiol       Date:  1977-08

7.  Vitamin K1 intestinal absorption in vivo: influence of luminal contents on transport.

Authors:  D Hollander; E Rim; K S Muralidhara
Journal:  Am J Physiol       Date:  1977-01

Review 8.  Clinically important drug interactions with anticoagulants. An update.

Authors:  S Harder; P Thürmann
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

9.  Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

Authors:  R Hull; J Hirsh; R Jay; C Carter; C England; M Gent; A G Turpie; D McLoughlin; P Dodd; M Thomas; G Raskob; P Ockelford
Journal:  N Engl J Med       Date:  1982-12-30       Impact factor: 91.245

10.  Optimal oral anticoagulant therapy in patients with mechanical heart valves.

Authors:  S C Cannegieter; F R Rosendaal; A R Wintzen; F J van der Meer; J P Vandenbroucke; E Briët
Journal:  N Engl J Med       Date:  1995-07-06       Impact factor: 91.245

  10 in total
  4 in total

1.  Main comedications associated with major bleeding during anticoagulant therapy with coumarins.

Authors:  Fernie Penning-van Beest; Joëlle Erkens; Karl-Uwe Petersen; Hans Rudolf Koelz; Ron Herings
Journal:  Eur J Clin Pharmacol       Date:  2005-06-10       Impact factor: 2.953

2.  The Rotterdam Study: 2012 objectives and design update.

Authors:  Albert Hofman; Cornelia M van Duijn; Oscar H Franco; M Arfan Ikram; Harry L A Janssen; Caroline C W Klaver; Ernst J Kuipers; Tamar E C Nijsten; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2011-08-30       Impact factor: 8.082

3.  The Rotterdam Study: objectives and design update.

Authors:  Albert Hofman; Monique M B Breteler; Cornelia M van Duijn; Gabriel P Krestin; Huibert A Pols; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Johannes R Vingerling; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2007-10-23       Impact factor: 8.082

4.  The Rotterdam Study: 2010 objectives and design update.

Authors:  Albert Hofman; Monique M B Breteler; Cornelia M van Duijn; Harry L A Janssen; Gabriel P Krestin; Ernst J Kuipers; Bruno H Ch Stricker; Henning Tiemeier; André G Uitterlinden; Johannes R Vingerling; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2009       Impact factor: 8.082

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.